{
  "id": 16696190,
  "title": "Boundless Bio director Kevin Tang buys $51,619 in BOLD shares",
  "url": "https://urgent.news/2026/10/27/boundless-bio-director-kevin-tang-buys-51-619-in-bold-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-27T02:31:11.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/boundless-bio-director-kevin-tang-buys-51619-in-bold-shares-93CH-4974086"
  },
  "original_language": "en",
  "account": "Kevin Tang, director of Boundless Bio Inc., has recently purchased a total of $51,619 worth of the company's shares. This acquisition took place between October 22 and October 26, 2026, with individual purchases ranging between $2.38 and $2.40 per share. The stock has seen significant growth, increasing over 100% year-to-date, currently trading at $2.41. InvestingPro's analysis suggests the stock is undervalued, with a Fair Value of $2.53. Mr. Tang, who owns 10% of the company, bought 21,640 shares, totaling 3,011,749 shares held through various entities. He is the sole manager of Tang Capital Management, LLC, and the sole director and CEO of Tang Capital Partners III, Inc. and IV, Inc., both wholly owned by Tang Capital Partners, LP.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}